病毒诱导的急性呼吸窘迫综合征通过心脏炎症反应导致心肌病
研究通过21例SARS-CoV-2相关ARDS死亡患者尸检心脏标本与33例其他原因死亡者对比,并在小鼠中比较SARS-CoV-2感染与Toll样受体配体及ACE2抑制剂诱导的无病毒ARDS模型。结果显示病毒性ARDS使心脏总巨噬细胞增多、CCR2+巨噬细胞比例升高,中和TNF-α可减少心脏单核细胞与炎症性MHCIIlo CCR2+巨噬细胞并保护心功能。
要点
- 病毒性ARDS可经全身免疫激活引起心脏巨噬细胞重塑,即使心脏内无病毒。
- SARS-CoV-2相关ARDS患者心脏总巨噬细胞及CCR2+巨噬细胞比例升高。
- 中和TNF-α可减轻病毒样ARDS小鼠的心脏炎症并保护心功能。
核心结论
- 病毒性ARDS通过扩增CCR2+巨噬细胞亚群促进心脏炎症,相关心脏表型可在心脏无病毒情况下由宿主免疫系统激活诱发。
研究设计与样本
- 尸检研究比较21例COVID-19合并SARS-CoV-2相关ARDS患者与33例其他原因死亡者的心脏巨噬细胞亚群。
- 小鼠实验比较SARS-CoV-2感染与经气管滴注Toll样受体配体及ACE2抑制剂诱导的无病毒ARDS模型的心脏免疫细胞动态。
主要发现
- 人心脏中SARS-CoV-2使总心脏巨噬细胞计数增加并提高CCR2+巨噬细胞比例。
- 小鼠中SARS-CoV-2与无病毒肺损伤均引起心脏驻留巨噬细胞显著重塑,重现CCR2+巨噬细胞的临床扩增。
- 对病毒样ARDS小鼠使用TNF-α中和抗体可减少心脏单核细胞与炎症性MHCIIlo CCR2+巨噬细胞,并保护心脏功能。
- 病毒样ARDS提高既往心力衰竭小鼠的死亡率。
临床怎么用
- 对病毒性ARDS患者应关注心脏炎症与心功能变化,尤其合并既往心力衰竭者死亡风险更高。
- TNF-α中和可能作为减轻病毒性ARDS相关心脏炎症的潜在干预方向,尚需临床验证。
局限性
- 人源数据来自尸检标本,样本量有限且为横断面观察。
- 小鼠模型采用Toll样受体配体与ACE2抑制剂模拟病毒样ARDS,不能完全等同真实病毒感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Viral infections can cause acute respiratory distress syndrome (ARDS), systemic inflammation, and secondary cardiovascular complications. Lung macrophage subsets change during ARDS, but the role of heart macrophages in cardiac injury during viral ARDS remains unknown. Here we investigate how immune signals typical for viral ARDS affect cardiac macrophage subsets, cardiovascular health, and systemic inflammation. METHODS: We assessed cardiac macrophage subsets using immunofluorescence histology of autopsy specimens from 21 patients with COVID-19 with SARS-CoV-2-associated ARDS and 33 patients who died from other causes. In mice, we compared cardiac immune cell dynamics after SARS-CoV-2 infection with ARDS induced by intratracheal instillation of Toll-like receptor ligands and an ACE2 (angiotensin-converting enzyme 2) inhibitor. RESULTS: In humans, SARS-CoV-2 increased total cardiac macrophage counts and led to a higher proportion of CCR2+ (C-C chemokine receptor type 2 positive) macrophages. In mice, SARS-CoV-2 and virus-free lung injury triggered profound remodeling of cardiac resident macrophages, recapitulating the clinical expansion of CCR2+ macrophages. Treating mice exposed to virus-like ARDS with a tumor necrosis factor α-neutralizing antibody reduced cardiac monocytes and inflammatory MHCIIlo CCR2+ macrophages while also preserving cardiac function. Virus-like ARDS elevated mortality in mice with pre-existing heart failure. CONCLUSIONS: Our data suggest that viral ARDS promotes cardiac inflammation by expanding the CCR2+ macrophage subset, and the associated cardiac phenotypes in mice can be elicited by activating the host immune system even without viral presence in the heart.
引用
- Grune J, Bajpai G, Ocak PT, et al. Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart. Circulation. 2024. PMID: 38506045. doi:10.1161/CIRCULATIONAHA.123.066433
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。